Shigeru Kinoshita

Safety and Efficacy of Mature Cultured Corneal Endothelial Cell Therapy (Vyznova) in Eyes With Declining Long-term Efficacy After Prototype Cell Transplantation

Purpose: To report the efficacy and safety of mature cultured corneal endothelial cell (CEC) transplantation using neltependocel combined with the Rho kinase inhibitor Y-27632 (Vyznova) in eyes with declining long-term efficacy after transplantation of immature cultured CECs (pro...